Anticoagulants - Revision history

Rossdonaldson1 at 16:39, 18 October 2023

2023-10-18T16:39:10Z

← Older revision		Revision as of 16:39, 18 October 2023
Line 26:		Line 26:
	**[[Dalteparin]]		**[[Dalteparin]]

	==Factor Xa Inhibitors==		==Parenteral Factor Xa Inhibitors==
			*[[Fondaparinux]]

			==Direct oral anticoagulants (DOACs)==
			===Factor Xa Inhibitors===
	''Inhibits Factor Xa, leading to inactivation of thrombin ''		''Inhibits Factor Xa, leading to inactivation of thrombin ''
	*[[Rivaroxaban]] (Xarelto)		*[[Rivaroxaban]] (Xarelto)
	*[[Apixaban]] (Eliquis)		*[[Apixaban]] (Eliquis)
	*[[Fondaparinux]]
	*[[Edoxaban]]		*[[Edoxaban]]

	==Direct Thrombin Inhibitors==		===Direct Thrombin Inhibitors===
	''Directly inhibits thrombin''		''Directly inhibits thrombin''
	*[[Dabigatran]]		*[[Dabigatran]]

Rossdonaldson1: /* Direct Thrombin Inhibitors */

2023-06-07T22:22:25Z

Direct Thrombin Inhibitors

← Older revision		Revision as of 22:22, 7 June 2023
Line 34:		Line 34:

	==Direct Thrombin Inhibitors==		==Direct Thrombin Inhibitors==
	''~~Self-explanatory~~''		''Directly inhibits thrombin''
	*[[Dabigatran]]		*[[Dabigatran]]
	*[[Argatroban]]		*[[Argatroban]]

Neil.m.young: /* See Also */

2022-04-03T14:48:14Z

Neil.m.young: /* Contraindications to AnticoagulationBates SM, Ginsberg JS. Treatment of deep-vein thrombosis. N Engl J Med. 2004;351(3):268–277.= */

2022-04-03T14:47:43Z

Contraindications to AnticoagulationBates SM, Ginsberg JS. Treatment of deep-vein thrombosis. N Engl J Med. 2004;351(3):268–277.=

← Older revision		Revision as of 14:47, 3 April 2022
Line 1:		Line 1:
	[[File:Anticoagulants.png\|thumb]]		[[File:Anticoagulants.png\|thumb]]

	==Contraindications to Anticoagulation<ref>Bates SM, Ginsberg JS. Treatment of deep-vein thrombosis. N Engl J Med. 2004;351(3):268–277.</ref>===		==Contraindications to Anticoagulation<ref>Bates SM, Ginsberg JS. Treatment of deep-vein thrombosis. N Engl J Med. 2004;351(3):268–277.</ref>==
	*Absolute:		*Absolute:
	**Active bleeding		**Active bleeding

Neil.m.young at 14:47, 3 April 2022

2022-04-03T14:47:29Z

← Older revision		Revision as of 14:47, 3 April 2022
Line 1:		Line 1:
	[[File:Anticoagulants.png\|thumb]]		[[File:Anticoagulants.png\|thumb]]

	==Contraindications to Anticoagulation<ref>Bates SM, Ginsberg JS. Treatment of deep-vein thrombosis. N Engl J Med. 2004;351(3):268–277.</ref>		==Contraindications to Anticoagulation<ref>Bates SM, Ginsberg JS. Treatment of deep-vein thrombosis. N Engl J Med. 2004;351(3):268–277.</ref>===
	*Absolute:		*Absolute:
	**Active bleeding		**Active bleeding

Elcatracho: /* See Also */

2021-03-08T16:18:43Z

Elcatracho: /* Vitamin K Antagonist */

2021-01-18T23:16:56Z

Vitamin K Antagonist

← Older revision		Revision as of 23:16, 18 January 2021
Line 1:		Line 1:
	[[File:Anticoagulants.png\|thumb]]		[[File:Anticoagulants.png\|thumb]]

			==Contraindications to Anticoagulation<ref>Bates SM, Ginsberg JS. Treatment of deep-vein thrombosis. N Engl J Med. 2004;351(3):268–277.</ref>
			*Absolute:
			**Active bleeding
			**Severe bleeding diathesis or platelet count <20K
			**Neurosurgery, ocular surgery, or intracranial bleeding in the last 10 days
			*Relative:
			**Mild-to-moderate bleeding diathesis or thrombocytopenia
			**Brain metastases
			**Recent major trauma
			**Major abdominal surgery within the past 2 days
			**GI or GU bleeding within the past 14 days
			**Endocarditis
			**Severe hypertension (>200/120mmHg) at presentation

	==Vitamin K Antagonist==		==Vitamin K Antagonist==

ClaireLewis at 22:38, 13 November 2016

2016-11-13T22:38:09Z

← Older revision		Revision as of 22:38, 13 November 2016
Line 28:		Line 28:
	*[[Anticoagulant reversal for life-threatening bleeds]]		*[[Anticoagulant reversal for life-threatening bleeds]]
	*[[Antiplatelet medications]]		*[[Antiplatelet medications]]

			[[Category:Pharmacology]]

ClaireLewis at 22:42, 12 November 2016

2016-11-12T22:42:47Z

← Older revision		Revision as of 22:42, 12 November 2016
Line 1:		Line 1:
			[[File:Anticoagulants.png\|thumb]]

	==Vitamin K Antagonist==		==Vitamin K Antagonist==
	''Blocks activation of vitamin K dependent prothrombotic factors II, VII, IX, X and blocks synthesis of vitamin K dependent ANTI-thrombotic proteins C and S''		''Blocks activation of vitamin K dependent prothrombotic factors II, VII, IX, X and blocks synthesis of vitamin K dependent ANTI-thrombotic proteins C and S''
Line 23:		Line 25:
	*[[Bivalirudin]]		*[[Bivalirudin]]

	~~[[File:Anticoagulants.png\|thumb]]~~
	==See Also==		==See Also==
	*[[Anticoagulant reversal for life-threatening bleeds]]		*[[Anticoagulant reversal for life-threatening bleeds]]
	*[[Antiplatelet medications]]		*[[Antiplatelet medications]]

ClaireLewis: Created page with "==Vitamin K Antagonist== ''Blocks activation of vitamin K dependent prothrombotic factors II, VII, IX, X and blocks synthesis of vitamin K dependent ANTI-thrombotic proteins C..."

2016-11-12T22:42:09Z

Created page with "==Vitamin K Antagonist== ''Blocks activation of vitamin K dependent prothrombotic factors II, VII, IX, X and blocks synthesis of vitamin K dependent ANTI-thrombotic proteins C..."

New page

==Vitamin K Antagonist==
''Blocks activation of vitamin K dependent prothrombotic factors II, VII, IX, X and blocks synthesis of vitamin K dependent ANTI-thrombotic proteins C and S''
*[[Warfarin]]

==Heparins==
''Bind to and activate antithrombin, which in turns inactivates factor Xa and thrombin''
*[[Unfractionated heparin]]
*[[Low molecular weight heparin]]
**[[Enoxaparin]] (Lovenox)
**[[Dalteparin]]

==Factor Xa Inhibitors==
''Inhibits Factor Xa, leading to inactivation of thrombin ''
*[[Rivaroxaban]] (Xarelto)
*[[Apixaban]] (Eliquis)
*[[Fondaparinux]]
*[[Edoxaban]]

==Direct Thrombin Inhibitors==
''Self-explanatory''
*[[Dabigatran]]
*[[Argatroban]]
*[[Bivalirudin]]

[[File:Anticoagulants.png|thumb]]
==See Also==
*[[Anticoagulant reversal for life-threatening bleeds]]
*[[Antiplatelet medications]]

← Older revision		Revision as of 14:48, 3 April 2022
Line 42:		Line 42:
	*[[Anticoagulant reversal for life-threatening bleeds]]		*[[Anticoagulant reversal for life-threatening bleeds]]
	*[[Antiplatelet medications]]		*[[Antiplatelet medications]]
			*[[Procedures in patients with coagulopathies]]

	==References==		==References==

	[[Category:Pharmacology]]		[[Category:Pharmacology]]

← Older revision		Revision as of 16:18, 8 March 2021
Line 42:		Line 42:
	*[[Anticoagulant reversal for life-threatening bleeds]]		*[[Anticoagulant reversal for life-threatening bleeds]]
	*[[Antiplatelet medications]]		*[[Antiplatelet medications]]

			==References==

	[[Category:Pharmacology]]		[[Category:Pharmacology]]